Researchers Submit Patent Application, "Systems And Reagents For Detection Of Free Monoclonal Immunoglobulin Light Chains In Biological Samples", for Approval (USPTO 20240003903).

A patent application has been submitted for a new system that can detect and measure free monoclonal immunoglobulin light chains in biological samples. These light chains are associated with certain types of cancer, including multiple myeloma. The current methods for detecting these light chains have limitations, so the proposed system aims to provide improved detection and quantitation. The method described in the patent application involves using immunofixation electrophoresis to identify the presence of these light chains in biological samples. This method could be used to diagnose diseases like multiple myeloma and guide treatment decisions. The patent application provides detailed steps and variations of the method for different sample types and conditions. [Extracted from the article]